Feedback / Questions
elritercept (KER-050) - Keros Therap
Elritercept: Regulatory submission for MDS in FY2027/FY2029
(Takeda)
-
Dec 13, 2024 -
R&D Day
Filing
•
Hematological Malignancies • Myelodysplastic Syndrome • Oncology
https://assets-dam.takeda.com/image/upload/Global/Investor/events/2024/RD_Presentation_2024_EN.pdf
Dec 13, 2024
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious